Jenacyclin en es it fr

Jenacyclin Brand names, Jenacyclin Analogs

Jenacyclin Brand Names Mixture

  • No information avaliable

Jenacyclin Chemical_Formula

C22H24N2O8

Jenacyclin RX_link

http://www.rxlist.com/cgi/generic/doxycyc.htm

Jenacyclin fda sheet

Jenacyclin FDA

Jenacyclin msds (material safety sheet)

Jenacyclin MSDS

Jenacyclin Synthesis Reference

C. R. Stephens et al.; J. Am. Chem. Soc. 80; 5324 (1958)

Jenacyclin Molecular Weight

444.435 g/mol

Jenacyclin Melting Point

201 oC

Jenacyclin H2O Solubility

630 mg/L

Jenacyclin State

Solid

Jenacyclin LogP

-1.219

Jenacyclin Dosage Forms

Tablet; Capsule; Gel; Liquid; Powder; Powder for solution

Jenacyclin Indication

For the treatment of the following infections:Rocky mountain spotted fever, typhus fever and the typhus group, Q fever, rickettsialpox, and tick fevers caused by Rickettsiae, Chancroid caused by Haemophilus ducreyi, Uncomplicated gonorrhea caused by Neisseria gonorrhoeae, Respiratory tract infections caused by Mycoplasma pneumoniae or Streptococcus pneumoniae. Lymphogranuloma ve

Jenacyclin Pharmacology

Doxycycline, a long-acting tetracycline derived from oxytetracycline, is used to inhibit bacterial protein synthesis and treat non-gonococcal urethritis and cervicitis, exacerbations of bronchitis in patients with COPD, and adult periodontitis.

Jenacyclin Absorption

completely absorbed after oral administration

Jenacyclin side effects and Toxicity

anorexia, nausea, diarrhoea, glossitis, dysphagia, enterocolitis and inflammatory lesions (with monilial overgrowth) in the anogenital region. skin reactions such as maculopapular and erythematous rashes, exfoliative dermatitis, photosensitivity, hypersensitivity reactions such as urticaria, angioneurotic oedema, anaphylaxis, anaphyl-actoid purpura, pericarditis, and exacerbation of systemic lupus erythematosus, benign intracranial hypertension in adults disappearing on discontinuation of the medicine, haematologic abnormalities such as haemolytic anaemia, thrombocytopenia, neutropenia, and eosinophilia. LD50=262 mg/kg(i.p. in rat)

Jenacyclin Patient Information

Jenacyclin Organisms Affected

Enteric bacteria and other eubacteria